A SNARE protective pool antagonizes APOL1 renal toxicity in Drosophila nephrocytes

被引:3
|
作者
Lee, Jin-Gu [1 ,2 ]
Fu, Yulong [1 ,4 ]
Zhu, Jun-yi [1 ,2 ]
Wen, Pei [1 ,2 ]
van de Leemput, Joyce [1 ,2 ]
Ray, Patricio E. [3 ]
Han, Zhe [1 ,2 ]
机构
[1] Univ Maryland, Ctr Precis Dis Modeling, Sch Med UMSOM, Dept Med, 670 West Baltimore St,4052 HSFIII, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA
[3] Univ Virginia, Child Hlth Res Ctr, Sch Med, Dept Pediat, 409 Lane Rd, Charlottesville, VA 22908 USA
[4] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35249 USA
关键词
SNARE proteins; SNARE protective pool; APOL1; Renal toxicity; Nephrocytes; Serum resistance-associated (SRA) protein; RISK VARIANTS; KIDNEY-DISEASE; AFRICAN-AMERICANS; GENE; CELL; CYTOTOXICITY; PROTEIN; INJURY;
D O I
10.1186/s13578-023-01147-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background People of Sub-Saharan African ancestry are at higher risk of developing chronic kidney disease (CKD), attributed to the Apolipoprotein L1 (APOL1) gene risk alleles (RA) G1 and G2. The underlying mechanisms by which the APOL1-RA precipitate CKD remain elusive, hindering the development of potential treatments.Results Using a Drosophila genetic modifier screen, we found that SNARE proteins (Syx7, Ykt6, and Syb) play an important role in preventing APOL1 cytotoxicity. Reducing the expression of these SNARE proteins significantly increased APOL1 cytotoxicity in fly nephrocytes, the equivalent of mammalian podocytes, whereas overexpression of Syx7, Ykt6, or Syb attenuated their toxicity in nephrocytes. These SNARE proteins bound to APOL1-G0 with higher affinity than APOL1-G1/G2, and attenuated APOL1-G0 cytotoxicity to a greater extent than either APOL1-RA.Conclusions Using a Drosophila screen, we identified SNARE proteins (Syx7, Ykt6, and Syb) as antagonists of APOL1-induced cytotoxicity by directly binding APOL1. These data uncovered a new potential protective role for certain SNARE proteins in the pathogenesis of APOL1-CKD and provide novel therapeutic targets for APOL1-associated nephropathies.
引用
收藏
页数:14
相关论文
共 39 条
  • [1] A SNARE protective pool antagonizes APOL1 renal toxicity in Drosophila nephrocytes
    Jin-Gu Lee
    Yulong Fu
    Jun-yi Zhu
    Pei Wen
    Joyce van de Leemput
    Patricio E. Ray
    Zhe Han
    Cell & Bioscience, 13
  • [2] APOL1 Renal-Risk Variants Induce Mitochondrial Dysfunction
    Ma, Lijun
    Chou, Jeff W.
    Snipes, James A.
    Bharadwaj, Manish S.
    Craddock, Ann L.
    Cheng, Dongmei
    Weckerle, Allison
    Petrovic, Snezana
    Hicks, Pamela J.
    Hemal, Ashok K.
    Hawkins, Gregory A.
    Miller, Lance D.
    Molina, Anthony J. A.
    Langefeld, Carl D.
    Murea, Mariana
    Parks, John S.
    Freedman, Barry I.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (04): : 1093 - 1105
  • [3] Endoplasmic reticulum-translocation is essential for APOL1 cellular toxicity
    Kruzel-Davila, Etty
    Bavli-Kertselli, Ira
    Ofir, Ayala
    Cheatham, Amber M.
    Shemer, Revital
    Zaknoun, Eid
    Chornyy, Sergiy
    Tabachnikov, Orly
    Davis, Shamara E.
    Khatua, Atanu K.
    Skorecki, Karl
    Popik, Waldemar
    ISCIENCE, 2022, 25 (01)
  • [4] APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R
    Okamoto, Koji
    Rausch, Jason W.
    Wakashin, Hidefumi
    Fu, Yulong
    Chung, Joon-Yong
    Dummer, Patrick D.
    Shin, Myung K.
    Chandra, Preeti
    Suzuki, Kosuke
    Shrivastav, Shashi
    Rosenberg, Avi Z.
    Hewitt, Stephen M.
    Ray, Patricio E.
    Noiri, Eisei
    Le Grice, Stuart F. J.
    Hoek, Maarten
    Han, Zhe
    Winkler, Cheryl A.
    Kopp, Jeffrey B.
    COMMUNICATIONS BIOLOGY, 2018, 1
  • [5] Comparative Analysis of the APOL1 Variants in the Genetic Landscape of Renal Carcinoma Cells
    Tzukerman, Maty
    Shamai, Yeela
    Abramovich, Ifat
    Gottlieb, Eyal
    Selig, Sara
    Skorecki, Karl
    CANCERS, 2022, 14 (03)
  • [6] APOL1 Genotype and Renal Function of Black Living Donors
    Doshi, Mona D.
    Ortigosa-Goggins, Mariella
    Garg, Amit X.
    Li, Lihua
    Poggio, Emilio D.
    Winkler, Cheryl A.
    Kopp, Jeffrey B.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (04): : 1309 - 1316
  • [7] Response to Mechanism of Action of APOL1 in Renal Allograft Survival (and Native CKD) Remains Unclear
    Reeves-Daniel, A. M.
    Divers, J.
    Langefeld, C. D.
    Freedman, B. I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (10) : 2260 - 2260
  • [8] APOL1 renal risk alleles in patients on chronic hemodialysis in Northwest of Iran
    Vahed, Sepideh Zuntmi
    Rikhtegar, Ehsan
    Attari, Vahideh Ebrahimzadeh
    Haghi, Mehdi
    Tolouian, Ramin
    Shojas, Mohammadali Mohajel
    Ardalan, Mohammadreza
    JOURNAL OF RENAL INJURY PREVENTION, 2019, 8 (03): : 199 - 203
  • [9] Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background
    Lannon, Herbert
    Shah, Shrijal S.
    Dias, Leny
    Blackler, Daniel
    Alper, Seth L.
    Pollak, Martin R.
    Friedman, David J.
    KIDNEY INTERNATIONAL, 2019, 96 (06) : 1303 - 1307
  • [10] Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease
    McCarthy, Gizelle M.
    Blasio, Angelo
    Donovan, Olivia G.
    Schaller, Lena B.
    Bock-Hughes, Althea
    Magraner, Jose M.
    Suh, Jung Hee
    Tattersfield, Calum F.
    Stillman, Isaac E.
    Shah, Shrijal S.
    Zsengeller, Zsuzsanna K.
    Subramanian, Balajikarthick
    Friedman, David J.
    Pollak, Martin R.
    DISEASE MODELS & MECHANISMS, 2021, 14 (08)